EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1, 2024.

加利福尼亚州埃尔卡洪（商业新闻短讯）--PURE Bioscience，Inc.（OTCQB:PURE）（“PURE”，“公司”或“我们”），专利无毒柠檬酸二氢银（SDC）抗菌剂的创造者，今天报道了Darin Zehr被任命为董事会成员，自2024年5月1日起生效。

Mr. Zehr joins as an independent director and will also serve as a member of PURE’s Audit Committee and Compensation Committee. Mr. Zehr brings extensive experience working in the food industry. Since 1990, he has held various roles in food quality and safety, sanitation, and operations management. He is the General Manager of Commercial Food Sanitation LLC (CFS).

泽尔先生担任独立董事，并将担任PURE审计委员会和薪酬委员会的成员。泽尔先生在食品行业拥有丰富的工作经验。自1990年以来，他在食品质量和安全、卫生和运营管理方面担任了各种角色。他是商业食品卫生有限责任公司（CFS）的总经理。

CFS, an Intralox Company, is a global food safety consulting and training organization that works across all food industry segments and has operations in North and South America, Europe, Asia, and Australia. Prior to this role, Mr. Zehr spent 22 years with Kraft Foods where he held numerous roles in operations, including Area Sanitation Manager, Business Unit Manager, and Plant Manager.

CFS是一家Intralox公司，是一家全球性食品安全咨询和培训组织，在所有食品行业领域开展工作，并在北美和南美、欧洲、亚洲和澳大利亚开展业务。在担任这一职务之前，泽尔先生在卡夫食品公司工作了22年，在运营中担任过许多职务，包括区域卫生经理、业务部门经理和工厂经理。

He is Treasurer of the Board of Directors for Beaver Camp, a non-profit Christian Camping establishment, a former board member of the New York State Cheese Manufacturer’s Association, and former board member of the Lewis County General Hospital. Mr. Zehr received a Bachelor of Science degree in Chemistry from The State University of New York (SUNY) at Oswego.

他是海狸营董事会的财务主管，海狸营是一家非营利性基督教露营机构，曾任纽约州奶酪制造商协会董事会成员，刘易斯县总医院董事会成员。泽尔先生获得了位于奥斯韦戈的纽约州立大学（SUNY）化学学士学位。

He lives in Northern New York with his wife of 30 years and has three adult children..

他与结婚30年的妻子住在纽约北部，有三个成年子女。。

Mr. Zehr said, “I am excited to join the Board of Directors and engage with this great team supporting a product line that adds so much value.”

泽尔先生说：“我很高兴能加入董事会，并与这个伟大的团队合作，支持一条增值如此之多的产品线。”

Robert Bartlett, Chief Executive Officer, said, “Mr. Zehr is a welcomed addition and we are honored to have his valuable food industry experience and insights on our Board.”

首席执行官罗伯特·巴特利特（RobertBartlett）表示：“泽尔先生是一位受欢迎的新成员，我们很荣幸在董事会拥有他宝贵的食品行业经验和见解。”

About PURE Bioscience, Inc.

关于PURE Bioscience，Inc。

PURE is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena. We provide solutions to combat the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented, stabilized ionic silver, and our initial products contain silver dihydrogen citrate, better known as SDC.

PURE专注于主要在食品安全领域开发和商业化我们的专有抗菌产品。我们提供解决方案，以应对病原体和卫生控制的健康和环境挑战。我们的技术平台基于获得专利的稳定离子银，我们的初始产品含有柠檬酸二氢银，也称为SDC。

This is a broad-spectrum, non-toxic antimicrobial agent, and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and mitigation of bacterial resistance. PURE’s mailing address of 771 Jamacha Rd.

这是一种广谱，无毒的抗菌剂，与其他化合物配方良好。作为一种平台技术，SDC因其优越的功效，降低的毒性和减轻细菌耐药性而区别于市场上现有的产品。PURE的通讯地址是Jamacha Rd 771。

#512, El Cajon, California 92019 (San Diego County area) serves as its official address for all business requirements. Additional information on PURE is available at www.purebio.com..

#512，El Cajon，California 92019（圣地亚哥县地区）作为其所有业务要求的官方地址。有关PURE的更多信息，请访问www.purebio.com。。

Forward-looking Statements: Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Statements in this press release, including quotes from management, concerning the Company’s expectations, plans, business outlook, future performance, future potential revenues, expected results of the Company’s marketing efforts, the execution of contracts under negotiation and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements.” Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from any forward-looking statements.

前瞻性声明：本新闻稿中包含的任何不描述历史事实的声明可能构成前瞻性声明，因为该术语在1995年《私人证券诉讼改革法案》中有定义。本新闻稿中有关公司预期、计划、业务前景、未来业绩、未来潜在收入、公司营销工作的预期结果、正在谈判的合同的执行以及关于对任何未来事件、条件、业绩或其他事项所作假设或预期的任何其他声明，包括管理层的引用，均为“前瞻性声明”。前瞻性声明固有地涉及风险和不确定性，可能导致我们的实际结果与任何前瞻性声明存在重大差异。

Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company’s current and future products and services in the marketplace, including the Company’s ability to convert successful evaluations and tests for PURE Control and PURE Hard Surface into customer orders and customers continuing to place product orders as expected and to expand their use of the Company’s products; the Company’s ability to maintain relationships with its partners and other counterparties; the Company’s ability to generate sufficient revenues and reduce its operating expenses in order to reach profitability; the Company’s ability to raise the funding required to support its continued operations and the implementation of its business plan; the ability of the Company to develop effective new products .

可能导致或促成此类差异的因素包括但不限于公司未能实施或以其他方式实现其拟议业务举措和计划的利益；在市场上接受公司当前和未来的产品和服务，包括公司将纯控制和纯硬表面的成功评估和测试转化为客户订单的能力，以及客户继续按预期下产品订单并扩大其对公司产品的使用的能力；公司与合作伙伴和其他交易对手保持关系的能力；公司产生足够收入和减少运营费用以实现盈利能力的能力；公司筹集所需资金以支持其持续经营和实施其业务计划的能力；公司开发有效新产品的能力。